Welcome to use AbleSci to get your papers. Our English Version is under development. You can temporarily use Google to translate AbleSci. Quite easy! Thank you!
SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
adeno
Lv7
3470 积分
2021-05-09 加入
最近求助
最近应助
互助留言
GDF15 enhances body weight and adiposity reduction in obese mice by leveraging the leptin pathway
2天前
已完结
A Double‐Blind, Randomized, Placebo‐Controlled, Phase 2 Trial of Obexelimab in Systemic Lupus Erythematosus with Exploration of Response Based on Gene Pathway Co‐Expression Patterns
3天前
已完结
Time-resolved live-cell spectroscopy reveals EphA2 multimeric assembly
3天前
已完结
PD-1 inhibits T cell actin remodeling at the immunological synapse independently of its signaling motifs
3天前
已完结
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
3天前
已完结
Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial
3天前
已完结
Somatic hypermutation introduces bystander mutations that prepare SARS-CoV-2 antibodies for emerging variants
3天前
已完结
Distinct cellular dynamics associated with response to CAR-T therapy for refractory B-cell lymphoma
4天前
已完结
KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape
4天前
已完结
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
4天前
已完结
没有进行任何应助
重新填写链接【积分已退回】
10个月前
点赞
11个月前
能否上传一个pdf版本,多谢!
1年前
题目不对,谢谢
1年前
标题不对,谢谢
1年前
找到了【积分已退回】
1年前
感谢
2年前
点赞
2年前
感谢
2年前
感谢
2年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论